These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11207643)

  • 21. Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of addison's disease: a randomized clinical trial.
    Oksnes M; Björnsdottir S; Isaksson M; Methlie P; Carlsen S; Nilsen RM; Broman JE; Triebner K; Kämpe O; Hulting AL; Bensing S; Husebye ES; Løvås K
    J Clin Endocrinol Metab; 2014 May; 99(5):1665-74. PubMed ID: 24517155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Replacement therapy of oral hydrocortisone in adrenal insufficiency: the influence of gastrointestinal factors.
    Lennernäs H; Skrtic S; Johannsson G
    Expert Opin Drug Metab Toxicol; 2008 Jun; 4(6):749-58. PubMed ID: 18611115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose hydrocortisone replacement is associated with improved arterial stiffness index and blood pressure dynamics in severely adrenocorticotrophin-deficient hypopituitary male patients.
    Behan LA; Carmody D; Rogers B; Hannon MJ; Davenport C; Tormey W; Smith D; Thompson CJ; Stanton A; Agha A
    Eur J Endocrinol; 2016 Jun; 174(6):791-9. PubMed ID: 27025241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circadian variation in serum cortisol during hydrocortisone replacement is not attributable to changes in cortisol-binding globulin concentrations.
    Chung TT; Gunganah K; Monson JP; Drake WM
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):496-500. PubMed ID: 26603673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diurnal variability of intraocular pressure].
    Jaén-Díaz JI; Cordero-García B; López-de-Castro F; de-Castro-Mesa C; Castilla-López-Madridejos F; Berciano-Martínez F
    Arch Soc Esp Oftalmol; 2007 Nov; 82(11):675-9. PubMed ID: 17979035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous subcutaneous hydrocortisone infusion in Addison's disease.
    Løvås K; Husebye ES
    Eur J Endocrinol; 2007 Jul; 157(1):109-12. PubMed ID: 17609409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11 beta-hydroxysteroid dehydrogenase activity.
    Gelding SV; Taylor NF; Wood PJ; Noonan K; Weaver JU; Wood DF; Monson JP
    Clin Endocrinol (Oxf); 1998 Feb; 48(2):153-62. PubMed ID: 9579226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuous subcutaneous hydrocortisone infusion therapy in Addison's disease: a randomized, placebo-controlled clinical trial.
    Gagliardi L; Nenke MA; Thynne TR; von der Borch J; Rankin WA; Henley DE; Sorbello J; Inder WJ; Torpy DJ
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4149-57. PubMed ID: 25127090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Agreement between diurnal variations of intraocular pressure by Tono-Pen and Goldmann applanation tonometer in patients on topical anti-glaucoma medication.
    Gupta S; Sinha G; Sharma R; Nayak B; Patil B; Kashyap B; Shameer A; Dada T
    Int Ophthalmol; 2016 Feb; 36(1):9-15. PubMed ID: 25820518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The diurnal variation of intraocular pressure in non-glaucomatous subjects: relevance in a clinical context.
    Pointer JS
    Ophthalmic Physiol Opt; 1997 Nov; 17(6):456-65. PubMed ID: 9666918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth hormone treatment in hypopituitary GH deficient adults reduces circulating cortisol levels during hydrocortisone replacement therapy.
    Rodríguez-Arnao J; Perry L; Besser GM; Ross RJ
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):33-7. PubMed ID: 8796136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulsatile luteinizing hormone secretion in patients with Addison's disease. Impact of glucocorticoid substitution.
    Hangaard J; Andersen M; Grodum E; Koldkjaer O; Hagen C
    J Clin Endocrinol Metab; 1998 Mar; 83(3):736-43. PubMed ID: 9506718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of two replacement regimens in primary adrenal insufficiency patients. effect on clinical symptoms, health-related quality of life and biochemical parameters.
    Alonso N; Granada ML; Lucas A; Salinas I; Reverter J; Oriol A; Sanmarti A
    J Endocrinol Invest; 2004 May; 27(5):449-54. PubMed ID: 15279078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth hormone (GH) secretion in primary adrenal insufficiency: effects of cortisol withdrawal and patterned replacement on GH pulsatility and circadian rhythmicity.
    Barkan AL; DeMott-Friberg R; Samuels MH
    Pituitary; 2000 Nov; 3(3):175-9. PubMed ID: 11383482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of circadian rhythm of blood pressure by cortisol in patients with hypopituitarism.
    Matsumura K; Abe I; Fukuhara M; Fujii K; Ohya Y; Okamura K; Fujishima M
    Clin Exp Hypertens; 1994 Jan; 16(1):55-66. PubMed ID: 8136775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Achieving a physiological cortisol profile with once-daily dual-release hydrocortisone: a pharmacokinetic study.
    Johannsson G; Lennernäs H; Marelli C; Rockich K; Skrtic S
    Eur J Endocrinol; 2016 Jul; 175(1):85-93. PubMed ID: 27129362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of third trimester of pregnancy on diurnal variation of ocular pressure.
    Qureshi IA; Xi XR; Wu XD; Pasha N; Huang YB
    Chin Med Sci J; 1997 Dec; 12(4):240-3. PubMed ID: 11360559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-term reproducibility of intraocular pressure and ocular perfusion pressure measurements in Chinese volunteers and glaucoma patients.
    Gao Y; Wan B; Li P; Zhang Y; Tang X
    BMC Ophthalmol; 2016 Aug; 16():145. PubMed ID: 27538515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modified-release hydrocortisone to provide circadian cortisol profiles.
    Debono M; Ghobadi C; Rostami-Hodjegan A; Huatan H; Campbell MJ; Newell-Price J; Darzy K; Merke DP; Arlt W; Ross RJ
    J Clin Endocrinol Metab; 2009 May; 94(5):1548-54. PubMed ID: 19223520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acutely raised corticotropin levels in Addison's disease are not associated with increased plasma arginine vasopressin and corticotropin-releasing factor concentrations in peripheral plasma.
    Wittert GA; Livesey JH; Florkowski C; Or HK; Donald RA; Espiner EA
    J Clin Endocrinol Metab; 1993 Jan; 76(1):192-6. PubMed ID: 8380605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.